NCT00024115 2015-04-28BL22 Immunotoxin in Treating Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaNational Cancer Institute (NCI)Phase 1 Withdrawn
NCT00324831 2013-12-18GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell LymphomaNational Cancer Institute (NCI)Phase 3 Suspended480 enrolled